Nippon India Pharma Fund - Direct (G) vs SBI Large Cap Fund - Direct (G)

Nippon India Pharma Fund - Direct (G) vs SBI Large Cap Fund - Direct (G)

stock1

Nippon India Pharma Fund - Direct (G)

7.4%

stock2

SBI Large Cap Fund - Direct (G)

1.89%

Loading chart...

About Fund

Deutsche Bank AG

Karvy Computershare Pvt. Ltd.

Citi Bank HDFC Bank Ltd. Stock Holding Corporation of India

Computer Age Management Services Pvt. Ltd Computronics Financial Services India Ltd Datamatics Financial Software Services Ltd

Very High Risk

5000

9044.23

1.12

634.5023

January 1, 2013

1

Very High Risk

5000

1.12

103.5855

January 1, 2013

0

14.01 %

19.35 %

7.4 %

11.54 %

10 %

1.89 %

Sailesh Raj Bhan

MBA (Finance), CFA.

Mr.Bhan is an MBA with specialization in Finance and CFA. Has over 9 Yrs. of experience in Equity Securities Research & Sequeir Investment Pvt. Ltd. for 5 years and with Emkay Share & stock Broker Pvt. Ltd. for 2 years.

Saurabh Pant

B.Com, MBE,C.F.A(USA) Level III candidate.

He has over 4 years of experience in Indian Capital Markets as a research analyst. He has been associated with SBIFMPL since May 2007.

Sohini Andani

B.Com,CA.,

Prior to joining SBI Mutual Fund she has worked with ING Investment Management Pvt. Ltd., ASK Raymond James & Associates Pvt. Ltd., LKP Shares & securities Ltd., Advani Share Broker Pvt. Ltd., CRISIL, and K R Choksey Shares & Securities Pvt. Ltd.

Get your FAQs right